These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 12393574)

  • 1. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature.
    Galli M; Luciani D; Bertolini G; Barbui T
    Blood; 2003 Mar; 101(5):1827-32. PubMed ID: 12393574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which antiphospholipid antibodies should be measured in the antiphospholipid syndrome?
    Galli M
    Haemostasis; 2000; 30 Suppl 2():57-62. PubMed ID: 11251342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thromboembolic risk in patients with high titre anticardiolipin and multiple antiphospholipid antibodies.
    Neville C; Rauch J; Kassis J; Chang ER; Joseph L; Le Comte M; Fortin PR
    Thromb Haemost; 2003 Jul; 90(1):108-15. PubMed ID: 12876633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
    Viveros ME; Cabiedes J; Reyes E; Cabral AR
    Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid antibodies in children without and in adults with and without thrombophilia.
    Siemens HJ; Gutsche S; Brückner S; Bucsky P; Katus HA
    Thromb Res; 2000 May; 98(4):241-7. PubMed ID: 10822070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study.
    Urbanus RT; Siegerink B; Roest M; Rosendaal FR; de Groot PG; Algra A
    Lancet Neurol; 2009 Nov; 8(11):998-1005. PubMed ID: 19783216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiphospholipid syndrome: state of the art with emphasis on laboratory evaluation.
    Greaves M
    Haemostasis; 2000; 30 Suppl 2():16-25. PubMed ID: 11251337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
    Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
    Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: a nationwide prospective study.
    Mustonen P; Lehtonen KV; Javela K; Puurunen M
    Lupus; 2014 Dec; 23(14):1468-76. PubMed ID: 25164304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiphospholipid antibodies.
    Triplett DA
    Clin Adv Hematol Oncol; 2003 Dec; 1(12):726-30. PubMed ID: 16258476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of vascular and pregnancy morbidity in patients with low vs. moderate-to-high titers of antiphospholipid antibodies.
    Ofer-Shiber S; Molad Y
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):261-6. PubMed ID: 25526601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus.
    Nojima J; Iwatani Y; Suehisa E; Kuratsune H; Kanakura Y
    Haematologica; 2006 May; 91(5):699-702. PubMed ID: 16627257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
    Ames PR; Pyke S; Iannaccone L; Brancaccio V
    Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance and predictive value of laboratory tests in thrombosis associated with antiphospolipid antibodies].
    Barbui T; Finazzi G; Galli M
    Ann Ital Med Int; 1997; 12(2):76-83. PubMed ID: 9333316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-beta2-glycoprotein I antibodies and ischemic stroke in a 20-month-old boy.
    Katsarou E; Attilakos A; Fessatou S; Tsapra H; Tzavara V; Dracou C
    Pediatrics; 2003 Jul; 112(1 Pt 1):188-90. PubMed ID: 12837887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
    Musial J; Swadzba J; Motyl A; Iwaniec T
    J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
    Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T
    Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
    Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
    J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of non-criteria antiphospholipid antibodies in patients with SLE: differentiation of thrombotic SLE patients and risk of recurrence of thrombosis.
    Tkachenko O; Lapin S; Mazing A; Emanuel V; Belolipetskaia E; Beliaeva I; Myachikova V; Maslyansky A; Schierack P; Roggenbuck D
    Lupus; 2020 Apr; 29(5):490-498. PubMed ID: 32131675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.